组蛋白去乙酰化酶2在慢性气道炎症性疾病糖皮质激素抵抗中的研究进展

doi:10.6040/j.issn.1673-3770.0.2024.134

摘要/Abstract

摘要： 慢性气道炎症性疾病是一类影响上下呼吸道以及肺实质的异质性疾病。糖皮质激素(glucocorticoid, GC)是目前临床上治疗该类疾病常用的抗炎药物之一,但部分患者给予足够的GC疗程后疗效不理想,即出现糖皮质激素抵抗(glucocorticoid resistance, GCR)现象,这为治疗该类疾病增加了困难,故阐明GCR的发病机理是其防治的关键。近年来相关研究提示,组蛋白去乙酰化酶2(histone deacetylase 2, HDAC2)表达水平及活性下降使糖皮质激素受体α(glucocorticoid receptor α, GRα)抑制促炎基因表达的能力降低进而导致GCR的发生,且慢性气道炎症性疾病中HDAC2表达水平和活性下降是气道氧化应激背景下HDAC2的共价修饰、磷脂酰肌醇-3-激酶(phosphatidylinositol-3-kinase, PI3K)/蛋白激酶B(protein kinase B, PKB/Akt)信号通路升高及STING通路激活的结果,这将为慢性气道炎症性疾病GC敏感性的恢复提供新的理论依据和思路。

关键词: 组蛋白去乙酰化酶2, 慢性气道炎症性疾病, 糖皮质激素, 糖皮质激素抵抗, 氧化应激

Abstract: Chronic airway inflammatory disease is a kind of heterogeneous disease affecting the upper and lower respiratory tracts and lung parenchyma. Glucocorticoid(GC)is one of the most commonly used anti-inflammatory drugs in the clinical treatment of these diseases. However, some patients with sufficient GC treatment have unsatisfactory efficacy, that is, the phenomenon of glucocorticoid resistance(GCR), increasing the difficulty in the treatment of these diseases. Therefore, elucidating the pathogenesis of GCR is the key to its prevention and treatment. In recent years, relevant studies have suggested that the decrease in histone deacetylase 2(HDAC2)expression level and activity reduces the ability of the glucocorticoid receptor α(GRα)to inhibit the expression of pro-inflammatory genes, leading to the occurrence of GCR. Furthermore, the decrease in HDAC2 expression and activity in chronic inflammatory diseases of the airways is the result of covalent modification of HDAC2, the increase of PI3Κ/Akt signaling pathway, and the activation of the STING pathway under the background of airway oxidative stress, which will provide a new theoretical basis and idea for recovering GC sensitivity in chronic inflammatory diseases of the airways.

Key words: Histone deacetylase 2, Chronic airway inflammatory disease, Glucocorticoid, Glucocorticoid resistance, Oxidative stress

中图分类号:

R563.9

段思妤,薛金梅. 组蛋白去乙酰化酶2在慢性气道炎症性疾病糖皮质激素抵抗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 120-126.

DUAN Siyu, XUE Jinmei. Research progress of histone deacetylase 2 in glucocorticoid resistance in chronic airway inflammatory diseases[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 120-126.

参考文献

[1] Li E, Knight JM, Wu YF, et al. Airway mycosis in allergic airway disease[J]. Adv Immunol, 2019, 142: 85-140. doi:10.1016/bs.ai.2019.05.002
[2] Klimek L, Sperl A, Becker S, et al. Current therapeutical strategies for allergic rhinitis[J]. Expert Opin Pharmacother, 2019, 20(1): 83-89. doi:10.1080/14656566.2018.1543401
[3] 资昊坤, 肖旭平, 李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103. doi:10.6040/j.issn.1673-3770.0.2020.428 ZI Haokun, XIAO Xuping, LI Yunqiu. Application status of oral corticosteroids during the perioperative period of chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 98-103. doi:10.6040/j.issn.1673-3770.0.2020.428
[4] Al-Ahmad M, Alsaleh S, Al-Reefy H, et al. Expert opinion on biological treatment of chronic rhinosinusitis with nasal polyps in the gulf region[J]. J Asthma Allergy, 2022, 15: 1-12. doi:10.2147/JAA.S321017
[5] Li JS, Chen RC, Yu XQ, et al. Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease(2022)[J]. J Evid Based Med, 2023, 16(4): 565-580. doi:10.1111/jebm.12578
[6] KRÄMER OH. HDAC2: a critical factor in health and disease[J]. Trends in Pharmacological Sciences, 2009, 30(12): 647-655. doi:10.1016/j.tips.2009.09.007
[7] Liu YR, Wang JQ, Huang ZG, et al. Histone deacetylase-2: a potential regulator and therapeutic target in liver disease(Review)[J]. Int J Mol Med, 2021, 48(1): 131. doi:10.3892/ijmm.2021.4964
[8] Footitt J, Mallia P, Durham AL, et al. Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of COPD[J]. Chest, 2016, 149(1): 62-73. doi:10.1378/chest.14-2637
[9] Hua HS, Wen HC, Lee HS, et al. Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by disrupting HDAC2/Sin3A/MeCP2 corepressor complex[J]. J Biomed Sci, 2023, 30(1): 40. doi:10.1186/s12929-023-00931-5
[10] Loke TK, Sousa AR, Corrigan CJ, et al. Glucocorticoid-resistant asthma[J]. Curr Allergy Asthma Rep, 2002, 2(2): 144-150. doi:10.1007/s11882-002-0009-y
[11] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(29): 1-464. doi:10.4193/Rhin20.600
[12] Persaud PN, Tran AP, Messner D, et al. Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life[J]. Ann Allergy Asthma Immunol, 2023, 131(6): 745-751,11. doi:10.1016/j.anai.2023.08.595
[13] Huang HM, Wang WQ. Molecular mechanisms of glucocorticoid resistance[J]. Eur J Clin Invest, 2023, 53(2): 13901. doi:10.1111/eci.13901
[14] Wang RY, Noddings CM, Kirschke E, et al. Structure of Hsp90-Hsp70-Hop-GR reveals the Hsp90 client-loading mechanism[J]. Nature, 2022, 601(7893): 460-464. doi:10.1038/s41586-021-04252-1
[15] 向治俞, 薛金梅. 糖皮质激素受体在慢性气道炎症性疾病激素抵抗中的研究进展[J]. 中国耳鼻咽喉颅底外科杂志, 2023, 29(4): 108-112. doi:10.11798/j.issn.1007-1520.202322239 XIANG Zhiyu, XUE Jinmei. Research progress of glucocorticoid receptors in corticosteroid resistance of chronic airway inflammatory diseases[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2023, 29(4): 108-112. doi:10.11798/j.issn.1007-1520.202322239
[16] Milara J, Morell A, de Diego A, et al. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma[J]. Allergy, 2019, 74(1): 111-121. doi:10.1111/all.13546
[17] Yang G, Suo LM, Geng XR, et al. An eosinophil-Sos1-RAS axis licenses corticosteroid resistance in patients with allergic rhinitis[J]. Immunobiology, 2022, 227(3): 152215. doi:10.1016/j.imbio.2022.152215
[18] Wang Y, Xiang ZY, An MM, et al. Livin promotes Th2-type immune response in airway allergic diseases[J]. Immunol Res, 2022, 70(5): 624-632. doi:10.1007/s12026-022-09294-9
[19] Xue JM, An YF, Suo LM, et al. Livin in synergy with Ras induces and sustains corticosteroid resistance in the airway mucosa[J]. Int J Biol Sci, 2021, 17(8): 2089-2098. doi:10.7150/ijbs.58427
[20] Weng JZ, Wang Y, Sun TY. Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats[J]. Chin Med J, 2019, 132(5): 569-576. doi:10.1097/CM9.0000000000000107
[21] Turner BM. Histone acetylation and an epigenetic code[J]. BioEssays, 2000, 22(9): 836-845. doi:10.1002/1521-1878(200009)22: 9<836: aid-bies9>3.3.co;2-o
[22] Scheinman RI, Gualberto A, Jewell CM, et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors[J]. Mol Cell Biol, 1995, 15(2): 943-953. doi:10.1128/MCB.15.2.943
[23] Li B, Carey M, Workman JL. The role of chromatin during transcription[J]. Cell, 2007, 128(4): 707-719. doi:10.1016/j.cell.2007.01.015
[24] John S, Sabo PJ, Johnson TA, et al. Interaction of the glucocorticoid receptor with the chromatin landscape[J]. Mol Cell, 2008, 29(5): 611-624. doi:10.1016/j.molcel.2008.02.010
[25] Li JW, Lin QS, Wang WD, et al. Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression[J]. Genes Dev, 2002, 16(6): 687-692. doi:10.1101/gad.962502
[26] Silverstein RA, Ekwall K. Sin3: a flexible regulator of global gene expression and genome stability[J]. Curr Genet, 2005, 47(1): 1-17. doi:10.1007/s00294-004-0541-5
[27] Allfrey VG, Mirsky AE. Structural modifications of histones and their possible role in the regulation of RNA synthesis[J]. Science, 1964, 144(3618): 559. doi:10.1126/science.144.3618.559
[28] Bin YF, Wu LJ, Sun XJ, et al. Expression of GR-α and HDAC2 in steroid-Sensitive and steroid-Insensitive interstitial lung disease[J]. Biomed Pharmacother, 2019, 118: 109380. doi:10.1016/j.biopha.2019.109380
[29] Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression[J]. J Exp Med, 2006, 203(1): 7-13. doi:10.1084/jem.20050466
[30] Marwick JA, Adcock IM, Chung KF. Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches[J]. Drugs, 2010, 70(8): 929-948. doi:10.2165/10898520-000000000-00000
[31] Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappa B and pro-inflammatory gene expression[J]. Biochem Pharmacol, 2004, 68(6): 1255-1267. doi:10.1016/j.bcp.2004.05.042
[32] Nadeem A, Alshehri S, Al-Harbi NO, et al. Bruton's tyrosine kinase inhibition suppresses neutrophilic inflammation and restores histone deacetylase 2 expression in myeloid and structural cells in a mixed granulocytic mouse model of asthma[J]. Int Immunopharmacol, 2023, 117: 109920. doi:10.1016/j.intimp.2023.109920
[33] Tao FL, Zhou YY, Wang MW, et al. Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway[J]. Korean J Physiol Pharmacol, 2022, 26(2): 95-111. doi:10.4196/kjpp.2022.26.2.95
[34] 张雅琪, 刘慧敏, 曹淋曼, 等. MAPK、PI3K-AKT、NF-κB在小鼠过敏性鼻炎中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 254-259. doi:10.6040 /j.issn.1673-3770.0.2021.174 ZHANG Yaqi, LIU Huimin, CAO Linman, et al. Expression and significance of MAPK, PI3K-AKT and NF-κB in mice allergic rhinitis[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2022,36(3):254-259. doi:10.6040/ j.issn.1673-3770.0.2021.174
[35] Mei D, Tan WSD, Wong WSF. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD[J]. Curr Opin Pharmacol, 2019, 46: 73-81. doi:10.1016/j.coph.2019.04.010
[36] Zhou PC, Ma JL, Yu W, et al. Tiao-bu-Fei-Shen formula improves glucocorticoid resistance of chronic obstructive pulmonary disease via downregulating the PI3K-akt signaling pathway and promoting GRα expression[J]. Evid Based Complement Alternat Med, 2023, 2023: 4359616. doi:10.1155/2023/4359616
[37] Wadhwa R, Dua K, Adcock IM, et al. Cellular mechanisms underlying steroid-resistant asthma[J]. Eur Respir Rev, 2019, 28(153): 190096. doi:10.1183/16000617.0096-2019
[38] Nascimento M, Gombault A, Lacerda-Queiroz N, et al. Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice[J]. Sci Rep, 2019, 9(1): 14848. doi:10.1038/s41598-019-51427-y
[39] Mdkhana B, Saheb Sharif-Askari N, Ramakrishnan RK, et al. Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease[J]. PLoS One, 2023, 18(7): 0284061. doi:10.1371/journal.pone.0284061
[40] Barnes PJ. Oxidative stress-based therapeutics in COPD[J]. Redox Biol, 2020, 33: 101544. doi:10.1016/j.redox.2020.101544
[41] Han M, Lee DB, Lee SH, et al. Oxidative stress and antioxidant pathway in allergic rhinitis[J]. Antioxidants, 2021, 10(8): 1266. doi:10.3390/antiox10081266
[42] Tai JH, Shin JM, Park J, et al. Oxidative stress and antioxidants in chronic rhinosinusitis with nasal polyps[J]. Antioxidants, 2023, 12(1): 195. doi:10.3390/antiox12010195
[43] Michaeloudes C, Abubakar-Waziri H, Lakhdar R, et al. Molecular mechanisms of oxidative stress in asthma[J]. Mol Aspects Med, 2022, 85: 101026. doi:10.1016/j.mam.2021.101026
[44] Soflaei SS, Momtazi-Borojeni AA, Majeed M, et al. Curcumin: a natural pan-HDAC inhibitor in cancer[J]. Curr Pharm Des, 2018, 24(2): 123-129. doi:10.2174/1381612823666171114165051
[45] Chen X, Wang D, Guo XJ, et al. Curcumin-loaded mPEG-PLGA nanoparticles attenuates the apoptosis and corticosteroid resistance induced by cigarette smoke extract[J]. Front Pharmacol, 2022, 13: 824652. doi:10.3389/fphar.2022.824652
[46] To Y, Ito K, Kizawa Y, et al. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2010, 182(7): 897-904. doi:10.1164/rccm.200906-0937OC
[47] Sun XJ, Li ZH, Zhang Y, et al. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(2): L139-L146. doi:10.1152/ajplung.00292.2014
[48] Luo QZ, Lin JT, Zhang L, et al. The anti-malaria drug artesunate inhibits cigarette smoke and ovalbumin concurrent exposure-induced airway inflammation and might reverse glucocorticoid insensitivity[J]. Int Immunopharmacol, 2015, 29(2): 235-245. doi:10.1016/j.intimp.2015.11.016
[49] Mercado N, To Y, Ito K, et al. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-Δ[J]. J Pharmacol Exp Ther, 2011, 337(2): 465-470. doi:10.1124/jpet.110.175950
[50] Xie T, Huang R, Deng DS, et al. Cryptotanshinone reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 797-809. doi:10.2147/COPD.S405757

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed